Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 22.96% vs -7.42% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 3.70% vs -32.74% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 49.38% vs 83.91% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -100.00% vs 100.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Tibet Aim Pharm., Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.87% vs 8.96% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 22.96% vs -7.42% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -55.45% vs 134.04% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 3.70% vs -32.74% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 27.81% vs -33.92% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 49.38% vs 83.91% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






